Khirurgiia
-
Comparative Study
[Cold injury as a cause of stable changes in microcirculation].
Using laser Doppler flowmetry comparative evaluation of microcirculatory condition and regulatory components of vascular tone in lower limbs was carried out in 40 patients with local cold injuries in late reactive period and 12 reconvalescents with trophic disturbances. Microcirculation index decreased in all patients while neurogenous and myogenous vascular tone increased. ⋯ At the same time in reconvalescents changes in passive regulatory components of vascular tone increase and frequency of peak amplitude neurogenous variation decrease. Thus, cold impact results in stable changes of microcirculation and therefore in dysthrophic changes in affected tissues.
-
Randomized Controlled Trial Comparative Study
[Clinicopathologic basis of ozonomagnetophoresis in treatment of festering wounds].
Results of treatment of 60 patients with festering wounds were comparatively studeid. According to the mode of local treatment the patients were divided into 2 groups: wound irrigation with ozone was carried out in the first group; in the second group local ozone therapy was carried out in combination with low-frequency magnetic fields--ozonomagnetophoresis. Bactericidal effect and antibiotic susceptibility of microflora is more marked using ozonomagnetophoresis. Tendency to purulo-necrotic tissue rejection from wound surface, regress of inflammation exudative stage with natural forming of granulation tissue in relatively short terms, its accelerated maturing and reparation are histologicaly marked.
-
Comparative Study
[The efficacy of alteplase in pulmonary embolism treatment].
The results of pulmonary embolism treatment with streptase in 76 patients are discussed. All patients had submassive or massive pulmonary embolism. 66 (86%) of patients recovered. ⋯ Authors consider alteplase to be highly effective in the treatment of massive pulmonary embolism. In case of late diagnostics of pulmonary embolism, especially recurrent, thrombolytic therapy remains to be effective up to 2 weeks after primary embolization.